Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification
Diagnostic Cytopathology · 2026-12 · 54 (12) · 881-900
DOI: 10.1002/dc.70196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostic Cytopathology, online erschienen am 25.08.2026. Verfasst von Boris M Shifman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Research Centre, Moscow, Russia. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Ministry of Health of the Russian Federation.
Abstract (Originalsprache)
Background
Cytological diagnosis of follicular neoplasm (FN; Bethesda IV) is associated with intermediate malignancy risk. Further stratification based on cytological features may be particularly relevant for non‐oncocytic FN but requires reliable, reproducible assessment approaches. This study evaluated cytological features of non‐oncocytic FN in terms of interobserver agreement and association with malignancy risk, and developed a cytological atypia scoring system for risk stratification.
Methods
This cross‐sectional study included adult patients who underwent surgery for non‐oncocytic FN. Cytological slides were independently reviewed by five cytopathologists. Fifteen cytological features were assessed; interobserver agreement and feature frequencies across histological outcome groups were evaluated.
Results
The final cohort included 200 cases: 80 malignant, 80 benign, and 40 low‐risk lesions. Eight cytological features showed acceptable interobserver agreement and different degrees of association with malignancy and were incorporated into the scoring system. The cytological atypia score was higher in malignant than in low‐risk and benign groups ( p < 0.001). ROC analysis yielded an AUC of 0.70 (95% CI, 0.63–0.76). Scores ≥ 4 points were associated with higher malignancy risk than scores of 0–3 points (OR = 3.87; 95% CI, 2.01–7.44; p < 0.001). An additional ≥ 8‐point threshold identified a high‐score subgroup with markedly increased malignancy risk compared with the 0–3‐point subgroup (OR = 9.22; 95% CI, 3.43–24.77; p < 0.001). Cytological atypia did not distinguish low‐risk tumours from benign lesions.
Conclusion
The most reproducible cytological features associated with malignancy risk were identified, and the proposed scoring system enabled stratification of non‐oncocytic FN by malignancy risk, potentially supporting individualised risk assessment after further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology Research Centre, Moscow, Russia.
ORCID-Profile: Boris M Shifman, Nadezhda M Platonova, Fatima M Abdulkhabirova, Ekaterina V Bondarenko, Anastasia M Lapshina, Liliya S Urusova, Georgii S Razmakhaev, Tatyana N Kamneva, Ekaterina A Troshina
Förderung
- Ministry of Health of the Russian Federation
Zitieren
APA
Shifman, B. M., Platonova, N. M., Abdulkhabirova, F. M., Bondarenko, E. V., Lapshina, A. M., Urusova, L. S., Razmakhaev, G. S., Kamneva, T. N., & Troshina, E. A. (2026). Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification. Diagnostic Cytopathology, 54(12), 881-900. https://doi.org/10.1002/dc.70196
Vancouver
Shifman BM, Platonova NM, Abdulkhabirova FM, Bondarenko EV, Lapshina AM, Urusova LS, et al. Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification. Diagnostic Cytopathology. 2026;54(12):881-900. doi:10.1002/dc.70196
BibTeX
@article{Shifman2026,
author = {Shifman, Boris M and Platonova, Nadezhda M and Abdulkhabirova, Fatima M and Bondarenko, Ekaterina V and Lapshina, Anastasia M and Urusova, Liliya S and Razmakhaev, Georgii S and Kamneva, Tatyana N and Troshina, Ekaterina A},
title = {Non‐Oncocytic Thyroid Follicular Neoplasm: Cytological Atypia and Development of a Score for Malignancy Risk Stratification},
journal = {Diagnostic Cytopathology},
year = {2026},
volume = {54},
number = {12},
pages = {881--900},
doi = {10.1002/dc.70196}
}
EUVIMED